169 related articles for article (PubMed ID: 32417924)
1. Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
de Lastours V; Laouénan C; Royer G; Carbonnelle E; Lepeule R; Esposito-Farèse M; Clermont O; Duval X; Fantin B; Mentré F; Decousser JW; Denamur E; Lefort A
J Antimicrob Chemother; 2020 Aug; 75(8):2334-2343. PubMed ID: 32417924
[TBL] [Abstract][Full Text] [Related]
2. Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort study.
Ling W; Paterson DL; Harris PNA; Furuya-Kanamori L; Edwards F; Laupland KB
Int J Infect Dis; 2024 Jan; 138():84-90. PubMed ID: 37949363
[TBL] [Abstract][Full Text] [Related]
3. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli.
Zhao S; Wu Y; Dai Z; Chen Y; Zhou X; Zhao J
Eur J Clin Microbiol Infect Dis; 2022 May; 41(5):713-721. PubMed ID: 35190911
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries.
Sokal A; Royer G; Esposito-Farese M; Clermont O; Condamine B; Laouénan C; Lefort A; Denamur E; de Lastours V;
J Infect Dis; 2024 Jun; 229(6):1679-1687. PubMed ID: 38214565
[TBL] [Abstract][Full Text] [Related]
6. Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing
Handal N; Whitworth J; Lyngbakken MN; Berdal JE; Dalgard O; Bakken Jørgensen S
Infect Dis (Lond); 2024 Jan; 56(1):19-31. PubMed ID: 37795955
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
[TBL] [Abstract][Full Text] [Related]
8. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL;
J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152
[TBL] [Abstract][Full Text] [Related]
9. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
Superti SV; Augusti G; Zavascki AP
Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.
Xiao T; Wu Z; Shi Q; Zhang X; Zhou Y; Yu X; Xiao Y
J Glob Antimicrob Resist; 2019 Jun; 17():147-156. PubMed ID: 30634054
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.
Wang S; Zhao SY; Xiao SZ; Gu FF; Liu QZ; Tang J; Guo XK; Ni YX; Han LZ
PLoS One; 2016; 11(1):e0147740. PubMed ID: 26824702
[TBL] [Abstract][Full Text] [Related]
16. Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence.
Fröding I; Hasan B; Sylvin I; Coorens M; Nauclér P; Giske CG
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423949
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
[TBL] [Abstract][Full Text] [Related]
18. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.
Tumbarello M; Spanu T; Di Bidino R; Marchetti M; Ruggeri M; Trecarichi EM; De Pascale G; Proli EM; Cauda R; Cicchetti A; Fadda G
Antimicrob Agents Chemother; 2010 Oct; 54(10):4085-91. PubMed ID: 20660675
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
